Home Tags Zydus

Tag: Zydus

Zydus Announces Positive Topline Results from Completed EVIDENCES-X Phase II(b) Clinical Trial of Saroglitazar Mg in MASH
Brands in Conversation

Zydus Announces Positive Topline Results from Completed EVIDENCES-X Phase II(b) Clinical Trial of Saroglitazar Mg in MASH

Author -
0
Zydus launches REVAHALE™, India’s first once-daily nebulised LAMA for COPD
Brands in Conversation

Zydus launches REVAHALE™, India’s first once-daily nebulised LAMA for COPD

Author -
0
Zydus marks Global Fatty Liver Day with the launch of new public awareness campaign – ‘Liver Ki Suno’
Brands in Conversation

Zydus marks Global Fatty Liver Day with the launch of new public awareness campaign – ‘Liver Ki Suno’

Author -
0
Zydus Gets Exclusive Licensing Rights For Next Gen Immuno-Oncology Platforms From The Us Based Agenus
Brands in Conversation

Zydus Gets Exclusive Licensing Rights For Next Gen Immuno-Oncology Platforms From The Us Based Agenus

Author -
0
Dr. Sharvil Patel, Managing Director, Zydus Lifesciences Limited,
Brands in Conversation

Zydus enters exclusive negotiations with PAI Partners and other shareholders to acquire a majority stake in Amplitude Surgical, France Completion of the transaction to be followed by mandatory simplified tender offer

Author -
0
Zydus
Brands in Conversation

Zydus Lifesciences- first in India to launch protection against new strain of influenza virus (Southern Hemisphere 2025)

Passionate in Marketing -
0
Zydus Lifesciences announces completion of Phase II(a) clinical trial of Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS)
Brands in Conversation

Zydus Lifesciences announces completion of Phase II(a) clinical trial of Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS)

Passionate in Marketing -
0
Zydus receives final approval from USFDA for Scopolamine Transdermal System 1 mg/3 days
Brands in Conversation

Zydus receives final approval from USFDA for Scopolamine Transdermal System 1 mg/3 days

Passionate in Marketing -
0
Zydus to acquire 50% stake in Sterling Biotech from Perfect Day to enter into fermentation-based protein business
Brands in Conversation

Zydus to acquire 50% stake in Sterling Biotech from Perfect Day to enter into fermentation-based protein business

Passionate in Marketing -
0